MYB-NFIB, MYBL1, and MYB in Breast Cancer: Oncogenic Roles and Therapeutic Implications
July 9th, 2025
MYB-NFIB, MYBL1, and MYB in Breast Cancer: Oncogenic Roles and Therapeutic Implications
Targeting ETV6-NTRK3 Fusion in Cancer with CRISPR-Cas9: Mechanisms and Therapeutic Potential
July 8th, 2025
Targeting ETV6-NTRK3 Fusion in Cancer with CRISPR-Cas9: Mechanisms and Therapeutic Potential
Immunotherapy Options for E-Cadherin-Negative Breast Cancer: Current Strategies and Future Directions
July 7th, 2025
Immunotherapy Options for E-Cadherin-Negative Breast Cancer: Current Strategies and Future Directions
CDH1 and CRISPR-Cas9: A Revolutionary Approach in Cancer Research and Therapy
July 2nd, 2025
CDH1 and CRISPR-Cas9: A Revolutionary Approach in Cancer Research and Therapy
PTEN Loss and AKT Activation in Triple-Negative Breast Cancer: Mechanisms and Therapeutic Implications
July 1st, 2025
PTEN Loss and AKT Activation in Triple-Negative Breast Cancer: Mechanisms and Therapeutic Implications
The Role of the PI3K/AKT/mTOR (PAM) Pathway in Breast Cancer: Mechanisms and Therapeutic Implications
June 30th, 2025
The Role of the PI3K/AKT/mTOR (PAM) Pathway in Breast Cancer: Mechanisms and Therapeutic Implications
Side Effects of Gene-Edited Breast Cancer Treatments
April 25th, 2025
Side Effects of Gene-Edited Breast Cancer Treatments
Can Gene Editing Prevent Hereditary Breast Cancer?
April 24th, 2025
Can Gene Editing Prevent Hereditary Breast Cancer?
Gene Editing Tools for Breast Cancer Research
April 23rd, 2025
Gene Editing Tools for Breast Cancer Research
共 11 条